Expanding the proteome of an RNA virus by phosphorylation of an intrinsically disordered viral protein

Journal of Biological Chemistry

Volumn 289, Issue 35, 2014, Pages 24397-24416

  Cordek, Daniel G ^a   Croom Perez, Tayler J ^a   Hwang, Jungwook ^c   Hargittai, Michele R S ^d   Subba Reddy, Chennareddy V ^e   Han, Qingxia ^a   Lodeiro, Maria Fernanda ^a   Ning, Gang ^b   McCrory, Thomas S ^a   Arnold, Jamie J ^a   Koc, Hasan ^f   Lindenbach, Brett D ^e   Showalter, Scott A ^a   Cameron, Craig E ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c Hanyang University   (South Korea)

^d SAINT FRANCIS UNIVERSITY   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MARSHALL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORYLATION; RNA; TRANSMISSION ELECTRON MICROSCOPY; VIRUSES;

CONFORMATIONAL ENSEMBLE; INTRINSIC DISORDER; INTRINSICALLY DISORDERED PROTEINS; MULTIDIMENSIONAL NMR; NONSTRUCTURAL PROTEINS; POST-TRANSLATIONAL MODIFICATIONS; SMALL MOLECULE INHIBITOR; SRC HOMOLOGY 3 DOMAINS;

PROTEINS;

ALANINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; NONSTRUCTURAL PROTEIN 5A; POLYAMINOACID; POLYPROLINE; PROTEIN TYROSINE KINASE; PROTEOME; THREONINE; UNCLASSIFIED DRUG; VIRUS RNA; INTRINSICALLY DISORDERED PROTEIN; PRIMER DNA; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IC 50; IMMUNOFLUORESCENCE MICROSCOPY; NITROGEN NUCLEAR MAGNETIC RESONANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEOMICS; SEQUENCE ALIGNMENT; STEADY STATE; TRANSMISSION ELECTRON MICROSCOPY; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS GENOME; VIRUS REPLICATION; AMINO ACID SEQUENCE; CELL LINE; GENETICS; HEPACIVIRUS; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELL LINE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DNA PRIMERS; HEPACIVIRUS; HUMANS; INTRINSICALLY DISORDERED PROTEINS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PROTEOME; RNA, VIRAL; TANDEM MASS SPECTROMETRY; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84906871865     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.589911     Document Type: Article

References (61)

1. Love, R. A., Brodsky, O., Hickey, M. J., Wells, P. A., and Cronin, C. N. (2009) Crystal structure of a novel dimeric form of NS5A domain I protein from hepatitis C virus. J. Virol. 83, 4395-4403
2. Tellinghuisen, T. L., Marcotrigiano, J., and Rice, C. M. (2005) Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase. Nature 435, 374-379 (Pubitemid 40745549)
3. Huang, L., Hwang, J., Sharma, S. D., Hargittai, M. R., Chen, Y., Arnold, J. J., Raney, K. D., and Cameron, C. E. (2005) Hepatitis C virus nonstructural protein 5A (NS5A) is an RNA-binding protein. J. Biol. Chem. 280, 36417-36428 (Pubitemid 41633916)
4. Hwang, J., Huang, L., Cordek, D. G., Vaughan, R., Reynolds, S. L., Kihara, G., Raney, K. D., Kao, C. C., and Cameron, C. E. (2010) Hepatitis C virus nonstructural protein 5A: biochemical characterization of a novel structural class of RNA-binding proteins. J. Virol. 84, 12480-12491
5. Hanoulle, X., Verdegem, D., Badillo, A., Wieruszeski, J. M., Penin, F., and Lippens, G. (2009) Domain 3 of non-structural protein 5A from hepatitis C virus is natively unfolded. Biochem. Biophys. Res. Commun. 381, 634-638
6. Liang, Y., Kang, C. B., and Yoon, H. S. (2006) Molecular and structural characterization of the domain 2 of hepatitis C virus non-structural protein 5A. Mol. Cells 22, 13-20 (Pubitemid 44323040)
7. Cordek, D. G., Bechtel, J. T., Maynard, A. T., Kazmierski, W. M., and Cameron, C. E. (2011) Targeting the NS5A protein of HCV: an emerging option. Drugs Future 36, 691-711
8. Uversky, V. N., Oldfield, C. J., and Dunker, A. K. (2008) Intrinsically disordered proteins in human diseases: introducing the D2 concept. Annu. Rev. Biophys. 37, 215-246
9. Blight, K. J., Kolykhalov, A. A., and Rice, C. M. (2000) Efficient initiation of HCV RNA replication in cell culture. Science 290, 1972-1974
10. Bukh, J., Pietschmann, T., Lohmann, V., Krieger, N., Faulk, K., Engle, R. E., Govindarajan, S., Shapiro, M., St Claire, M., and Bartenschlager, R. (2002) Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc. Natl. Acad. Sci. U.S.A. 99, 14416-14421 (Pubitemid 35257686)
11. Yi, M., Hu, F., Joyce, M., Saxena, V., Welsch, C., Chavez, D., Guerra, B., Yamane, D., Veselenak, R., Pyles, R., Walker, C. M., Tyrrell, L., Bourne, N., Lanford, R. E., and Lemon, S. M. (2014) Evolution of a cell culture-derived genotype 1a hepatitis C virus (H77S.2) during persistent infection with chronic hepatitis in a chimpanzee. J. Virol. 88, 3678-3694
12. Quintavalle, M., Sambucini, S., Di Pietro, C., De Francesco, R., and Neddermann, P. (2006) The α isoform of protein kinase CKI is responsible for hepatitis C virus NS5A hyperphosphorylation. J. Virol. 80, 11305-11312 (Pubitemid 44706570)
13. Neddermann, P., Quintavalle, M., Di Pietro, C., Clementi, A., Cerretani, M., Altamura, S., Bartholomew, L., and De Francesco, R. (2004) Reduction of hepatitis C virus NS5A hyperphosphorylation by selective inhibition of cellular kinases activates viral RNA replication in cell culture. J. Virol. 78, 13306-13314 (Pubitemid 39507835)
14. Gao, M., Nettles, R. E., Belema, M., Snyder, L. B., Nguyen, V. N., Fridell, R. A., Serrano-Wu, M. H., Langley, D. R., Sun, J. H., O'Boyle, D. R., 2nd, Lemm, J. A., Wang, C., Knipe, J. O., Chien, C., Colonno, R. J., Grasela, D. M., Meanwell, N. A., and Hamann, L. G. (2010) Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature 465, 96-100
15. Lemm, J. A., O'Boyle, D., 2nd, Liu, M., Nower, P. T., Colonno, R., Deshpande, M. S., Snyder, L. B., Martin, S. W., St Laurent, D. R., Serrano-Wu, M. H., Romine, J. L., Meanwell, N. A., and Gao, M. (2010) Identification of hepatitis C virus NS5A inhibitors. J. Virol. 84, 482-491
16. Appel, N., Pietschmann, T., and Bartenschlager, R. (2005) Mutational analysis of hepatitis C virus nonstructural protein 5A: potential role of differential phosphorylation in RNA replication and identification of a genetically flexible domain. J. Virol. 79, 3187-3194 (Pubitemid 40270599)
17. Tellinghuisen, T. L., Foss, K. L., and Treadaway, J. (2008) Regulation of hepatitis C virion production via phosphorylation of the NS5A protein. PLoS Pathog. 4, e1000032
18. Huang, L., Sineva, E. V., Hargittai, M. R., Sharma, S. D., Suthar, M., Raney, K. D., and Cameron, C. E. (2004) Purification and characterization of hepatitis C virus non-structural protein 5A expressed in Escherichia coli. Protein Expr. Purif. 37, 144-153 (Pubitemid 39027254)
19. Phan, T., Beran, R. K., Peters, C., Lorenz, I. C., and Lindenbach, B. D. (2009) HepatitisCvirus NS2 protein contributes to virus particle assembly via opposing epistatic interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes. J. Virol. 83, 8379-8395
20. Wang, Q., Arnold, J. J., Uchida, A., Raney, K. D., and Cameron, C. E. (2010) Phosphate release contributes to the rate-limiting step for unwinding by an RNA helicase. Nucleic Acids Res. 38, 1312-1324
21. Zhong, W., Ferrari, E., Lesburg, C. A., Maag, D., Ghosh, S. K., Cameron, C. E., Lau, J. Y., and Hong, Z. (2000) Template/primer requirements and single nucleotide incorporation by hepatitis C virus nonstructural protein 5B polymerase. J. Virol. 74, 9134-9143
22. Kuiken, C., Yusim, K., Boykin, L., and Richardson, R. (2005) The Los Alamos hepatitis C sequence database. Bioinformatics 21, 379-384 (Pubitemid 40246609)
23. Gohara, D. W., Ha, C. S., Kumar, S., Ghosh, B., Arnold, J. J., Wisniewski, T. J., and Cameron, C. E. (1999) Production of "authentic" poliovirus RNA-dependent RNA polymerase (3D(pol)) by ubiquitin-protease- mediated cleavage in Escherichia coli. Protein Expr. Purif. 17, 128-138 (Pubitemid 29504387)
24. Studier, F. W. (2005) Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif. 41, 207-234
25. Sahu, D., Bastidas, M., and Showalter, S. (2014) Generating NMR chemical shift assignments of intrinsically disordered proteins using carbon-detected NMR methods. Anal. Biochem. 449, 17-25
26. Goddard, T. D., and Kneller, D. G. (2006) SPARKY, version 3.113, University of California, San Francisco
27. Kaneko, T., Tanji, Y., Satoh, S., Hijikata, M., Asabe, S., Kimura, K., and Shimotohno, K. (1994) Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. Biochem. Biophys. Res. Commun. 205, 320-326 (Pubitemid 24381628)
28. Katze, M. G., Kwieciszewski, B., Goodlett, D. R., Blakely, C. M., Neddermann, P., Tan, S. L., and Aebersold, R. (2000) Ser2194 is a highly conserved major phosphorylation site of the hepatitis C virus nonstructural protein NS5A. Virology 278, 501-513 (Pubitemid 32012784)
29. Nordle Gilliver, A., Griffin, S., and Harris, M. (2010) Identification of a novel phosphorylation site in hepatitis C virus NS5A. J. Gen. Virol. 91, 2428-2432
30. Reed, K. E., and Rice, C. M. (1999) Identification of the major phosphorylation site of the hepatitis C virus H strain NS5A protein as serine 2321. J. Biol. Chem. 274, 28011-28018
31. Lemay, K. L., Treadaway, J., Angulo, I., and Tellinghuisen, T. L. (2013) A hepatitis C virus NS5A phosphorylation site that regulates RNA replication. J. Virol. 87, 1255-1260
32. Ross-Thriepland, D., and Harris, M. (2014) Insights into the complexity and functionality of hepatitis C virus NS5A phosphorylation. J. Virol. 88, 1421-1432
33. Ide, Y., Tanimoto, A., Sasaguri, Y., and Padmanabhan, R. (1997) Hepatitis C virus NS5A protein is phosphorylated in vitro by a stably bound protein kinase from HeLa cells and by cAMP-dependent protein kinase A-α catalytic subunit. Gene 201, 151-158 (Pubitemid 27504089)
34. Ide, Y., Zhang, L., Chen, M., Inchauspe, G., Bahl, C., Sasaguri, Y., and Padmanabhan, R. (1996) Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A. Gene 182, 203-211 (Pubitemid 27007186)
35. Macdonald, A., Crowder, K., Street, A., McCormick, C., and Harris, M. (2004) The hepatitis C virus NS5A protein binds to members of the Src family of tyrosine kinases and regulates kinase activity. J. Gen. Virol. 85, 721-729 (Pubitemid 38379876)
36. Tan, S. L., Nakao, H., He, Y., Vijaysri, S., Neddermann, P., Jacobs, B. L., Mayer, B. J., and Katze, M. G. (1999) NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc. Natl. Acad. Sci. U.S.A. 96, 5533-5538 (Pubitemid 29234652)
37. Lohmann, V., Körner, F., Koch, J., Herian, U., Theilmann, L., and Bartenschlager, R. (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110-113 (Pubitemid 29307577)
38. Macdonald, A., Mazaleyrat, S., McCormick, C., Street, A., Burgoyne, N. J., Jackson, R. M., Cazeaux, V., Shelton, H., Saksela, K., and Harris, M. (2005) Further studies on hepatitisCvirus NS5A-SH3 domain interactions: identification of residues critical for binding and implications for viral RNA replication and modulation of cell signalling. J. Gen. Virol. 86, 1035-1044 (Pubitemid 40485661)
39. Feuerstein, S., Solyom, Z., Aladag, A., Favier, A., Schwarten, M., Hoffmann, S., Willbold, D., and Brutscher, B. (2012) Transient structure and SH3 interaction sites in an intrinsically disordered fragment of the hepatitis C virus protein NS5A. J. Mol. Biol. 420, 310-323
40. Elam, W. A., Schrank, T. P., Campagnolo, A. J., and Hilser, V. J. (2013) Evolutionary conservation of the polyproline II conformation surrounding intrinsically disordered phosphorylation sites. Protein Sci. 22, 405-417
41. Hughes, M., Gretton, S., Shelton, H., Brown, D. D., McCormick, C. J., Angus, A. G., Patel, A. H., Griffin, S., and Harris, M. (2009) A conserved proline between domains II and III of hepatitis C virus NS5A influences both RNA replication and virus assembly. J. Virol. 83, 10788-10796
42. Pfannkuche, A., Büther, K., Karthe, J., Poenisch, M., Bartenschlager, R., Trilling, M., Hengel, H., Willbold, D., Häussinger, D., and Bode, J. G. (2011) c-Src is required for complex formation between the hepatitis C virus-encoded proteins NS5A and NS5B: a prerequisite for replication. Hepatology 53, 1127-1136
43. Martin-Garcia, J. M., Luque, I., Ruiz-Sanz, J., and Camara-Artigas, A. (2012) The promiscuous binding of the Fyn SH3 domain to a peptide from the NS5A protein. Acta Crystallogr. D Biol. Crystallogr. 68, 1030-1040
44. Egger, D., Wölk, B., Gosert, R., Bianchi, L., Blum, H. E., Moradpour, D., and Bienz, K. (2002) Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J. Virol. 76, 5974-5984 (Pubitemid 34556292)
45. Adler, J., and Parmryd, I. (2010) Quantifying colocalization by correlation: the Pearson correlation coefficient is superior to the Mander's overlap coefficient. Cytometry A 77, 733-742
46. Kase, H., Iwahashi, K., Nakanishi, S., Matsuda, Y., Yamada, K., Takahashi, M., Murakata, C., Sato, A., and Kaneko, M. (1987) K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun. 142, 436-440 (Pubitemid 17003365)
47. Hidaka, H., Inagaki, M., Kawamoto, S., and Sasaki, Y. (1984) Isoquinoline-sulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23, 5036-5041 (Pubitemid 15206436)
48. Chijiwa, T., Mishima, A., Hagiwara, M., Sano, M., Hayashi, K., Inoue, T., Naito, K., Toshioka, T., and Hidaka, H. (1990) Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265, 5267-5272
49. Glass, D. B., Cheng, H. C., Mende-Mueller, L., Reed, J., and Walsh, D. A. (1989) Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor protein. J. Biol. Chem. 264, 8802-8810 (Pubitemid 19151602)
50. Dyson, H. J. (2011) Expanding the proteome: disordered and alternatively folded proteins. Q. Rev. Biophys. 44, 467-518
51. Joerger, A. C., and Fersht, A. R. (2010) The tumor suppressor p53: from structures to drug discovery. Cold Spring Harb. Perspect. Biol. 2, a000919
52. Moriishi, K., and Matsuura, Y. (2007) Host factors involved in the replication of hepatitis C virus. Rev. Med. Virol. 17, 343-354 (Pubitemid 47425871)
53. Backes, P., Quinkert, D., Reiss, S., Binder, M., Zayas, M., Rescher, U., Gerke, V., Bartenschlager, R., and Lohmann, V. (2010) Role of annexin A2 in the production of infectious hepatitis C virus particles. J. Virol. 84, 5775-5789
54. Saxena, V., Lai, C. K., Chao, T. C., Jeng, K. S., and Lai, M. M. (2012) Annexin A2 is involved in the formation of hepatitis C virus replication complex on the lipid raft. J. Virol. 86, 4139-4150
55. Burckstümmer, T., Kriegs, M., Lupberger, J., Pauli, E. K., Schmittel, S., and Hildt, E. (2006) Raf-1 kinase associates with hepatitis C virus NS5A and regulates viral replication. FEBS Lett. 580, 575-580 (Pubitemid 43089688)
56. Tamma, G., Procino, G., Mola, M. G., Svelto, M., and Valenti, G. (2008) Functional involvement of Annexin-2 incAMPinduced AQP2 trafficking. Pflugers Arch. 456, 729-736
57. Dumaz, N., and Marais, R. (2003) Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras. J. Biol. Chem. 278, 29819-29823 (Pubitemid 36962369)
58. Grieco, D., Porcellini, A., Avvedimento, E. V., and Gottesman, M. E. (1996) Requirement for cAMP-PKA pathway activation by M phase-promoting factor in the transition from mitosis to interphase. Science 271, 1718-1723 (Pubitemid 26102818)
59. Targett-Adams, P., Graham, E. J., Middleton, J., Palmer, A., Shaw, S. M., Lavender, H., Brain, P., Tran, T. D., Jones, L. H., Wakenhut, F., Stammen, B., Pryde, D., Pickford, C., and Westby, M. (2011) Small molecules targeting hepatitis C virus-encoded NS5A cause subcellular redistribution of their target: insights into compound modes of action. J. Virol. 85, 6353-6368
60. Blight, K. J., McKeating, J. A., and Rice, C. M. (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76, 13001-13014 (Pubitemid 35386984)
61. Xu, W., Harrison, S. C., and Eck, M. J. (1997) Three-dimensional structure of the tyrosine kinase c-Src. Nature 385, 595-602 (Pubitemid 27087566)